Methodological Issues in Designing a Randomized Controlled Trial for Psychotic Depression: The STOP-PD Study
| dc.contributor.author | Meyers, Barnett S. | |
| dc.contributor.author | Peasley-Miklus, Catherine | |
| dc.contributor.author | Flint, Alastair J. | |
| dc.contributor.author | Mulsant, Benoit H. | |
| dc.contributor.author | Rothschild, Anthony J. | |
| dc.date | 2022-08-11T08:10:31.000 | |
| dc.date.accessioned | 2022-08-23T17:11:56Z | |
| dc.date.available | 2022-08-23T17:11:56Z | |
| dc.date.issued | 2006-01-01 | |
| dc.date.submitted | 2010-05-13 | |
| dc.identifier.citation | Meyers BS, Peasley-Miklus C, Flint AJ, Mulsant BH, Rothschild AJ: Methodological Issues In Designing A Randomized Controlled Trial For Psychotic Depression: The STOP-PD Study. Psych Annals, 2006; 36:57-64. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/46396 | |
| dc.description.abstract | The safety and efficacy of electroconvulsive therapy (ECT) has been documented for more than half a century, including among patients with major depressive disorder with psychotic features (MD-Psy) who have failed intensive antidepressant treatment. More recent studies from academic centers that use contemporary ECT standards have demonstrated response and remission rates exceeding 90% among patients with MD-Psy. | |
| dc.language.iso | en_US | |
| dc.relation.url | http://www.psychiatricannalsonline.com/view.asp?rid=20651 | |
| dc.subject | Depressive Disorder, Major | |
| dc.subject | Affective Disorders, Psychotic | |
| dc.subject | Psychiatry | |
| dc.title | Methodological Issues in Designing a Randomized Controlled Trial for Psychotic Depression: The STOP-PD Study | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Psychiatric Annals | |
| dc.source.volume | 36 | |
| dc.source.issue | 1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/psych_pp/97 | |
| dc.identifier.contextkey | 1310043 | |
| html.description.abstract | <p>The safety and efficacy of electroconvulsive therapy (ECT) has been documented for more than half a century, including among patients with major depressive disorder with psychotic features (MD-Psy) who have failed intensive antidepressant treatment. More recent studies from academic centers that use contemporary ECT standards have demonstrated response and remission rates exceeding 90% among patients with MD-Psy.</p> | |
| dc.identifier.submissionpath | psych_pp/97 | |
| dc.contributor.department | Department of Psychiatry | |
| dc.source.pages | 57-64 |